CONMED (CNMD) Research Hub

CONMED (CNMD) trades on NYSE, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 47.68 USD (-3.19%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 23.70, market cap 1.26B. This hub links to the full technical, earnings and options research available for CNMD.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Devices)
ExchangeNYSE, US
Last close47.68 USD (-3.19%)
52-week range31.44 USD – 52.2 USD
Trend regimeRange
14-day RSI62.3 (Bullish)
Trailing P/E23.70
Market cap1.26B
Dividend yield0.48%
Next earnings2026-07-29

Available research for CNMD

Earnings

CNMD earnings date and last-quarter result: next report 2026-07-29, last quarter beat, P/E 23.70. Updated 2026-07-23.

Options: Covered Call

Covered Call on CNMD: how it works, illustrative setup around the real 47.68 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on CNMD: how it works, illustrative setup around the real 47.68 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on CNMD: how it works, illustrative setup around the real 47.68 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

CNMD technical analysis: range, last 47.68 USD, RSI 62.3, 52w range 31.44 USD–52.2 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is CNMD in?

CONMED (CNMD) is classified under Healthcare (Medical - Devices), listed on NYSE, US.

Is CNMD in an uptrend or downtrend?

As of 2026-10-26, CNMD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is CNMD's trailing P/E ratio?

CNMD's trailing P/E is 23.70, with a market cap of 1.26B. See the earnings research page for full valuation detail.

When does CNMD next report earnings?

CNMD is next scheduled to report earnings on 2026-07-29.